Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

HER2 Expression in Gastric Adenocarcinoma-a Study in a Tertiary Care Centre in South India.

Aditi R, Aarathi R, Pradeep R, Hemalatha L, Akshatha C, Amar K.

Indian J Surg Oncol. 2016 Mar;7(1):18-24. doi: 10.1007/s13193-015-0436-6. Epub 2015 Jul 4.

2.

Proficiency testing in immunohistochemistry--experiences from Nordic Immunohistochemical Quality Control (NordiQC).

Vyberg M, Nielsen S.

Virchows Arch. 2016 Jan;468(1):19-29. doi: 10.1007/s00428-015-1829-1. Epub 2015 Aug 26.

3.
4.

The use of mouse models of breast cancer and quantitative image analysis to evaluate hormone receptor antigenicity after microwave-assisted formalin fixation.

Engelberg JA, Giberson RT, Young LJ, Hubbard NE, Cardiff RD.

J Histochem Cytochem. 2014 May;62(5):319-34. doi: 10.1369/0022155414529250. Epub 2014 Mar 28.

5.

Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.

McCormack VA, Joffe M, van den Berg E, Broeze N, Silva Idos S, Romieu I, Jacobson JS, Neugut AI, Schüz J, Cubasch H.

Breast Cancer Res. 2013;15(5):R84.

6.

Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues.

Neumeister VM, Anagnostou V, Siddiqui S, England AM, Zarrella ER, Vassilakopoulou M, Parisi F, Kluger Y, Hicks DG, Rimm DL.

J Natl Cancer Inst. 2012 Dec 5;104(23):1815-24. doi: 10.1093/jnci/djs438. Epub 2012 Oct 22.

7.

Detection and segmentation of cell nuclei in virtual microscopy images: a minimum-model approach.

Wienert S, Heim D, Saeger K, Stenzinger A, Beil M, Hufnagl P, Dietel M, Denkert C, Klauschen F.

Sci Rep. 2012;2:503. doi: 10.1038/srep00503. Epub 2012 Jul 11.

8.

Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry.

Schoenherr RM, Whiteaker JR, Zhao L, Ivey RG, Trute M, Kennedy J, Voytovich UJ, Yan P, Lin C, Paulovich AG.

Proteomics. 2012 Apr;12(8):1253-60. doi: 10.1002/pmic.201100587.

9.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC.

Arch Pathol Lab Med. 2010 Jun;134(6):907-22. doi: 10.1043/1543-2165-134.6.907. Erratum in: Arch Pathol Lab Med. 2010 Aug;134(8):1101.

10.

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC.

J Clin Oncol. 2010 Jun 1;28(16):2784-95. doi: 10.1200/JCO.2009.25.6529. Epub 2010 Apr 19. Review. Erratum in: J Clin Oncol. 2010 Jul 20;28(21):3543.

11.

Antibody validation.

Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, Anagnostou V, Rimm D.

Biotechniques. 2010 Mar;48(3):197-209. doi: 10.2144/000113382. Review. Erratum in: Biotechniques. 2010 May;48(5):351.

12.

Analytic variability in immunohistochemistry biomarker studies.

Anagnostou VK, Welsh AW, Giltnane JM, Siddiqui S, Liceaga C, Gustavson M, Syrigos KN, Reiter JL, Rimm DL.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):982-91. doi: 10.1158/1055-9965.EPI-10-0097. Epub 2010 Mar 23.

13.

Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients.

Uy GB, Laudico AV, Carnate JM Jr, Lim FG, Fernandez AM, Rivera RR, Mapua CA, Love RR.

Clin Breast Cancer. 2010 Apr;10(2):154-9. doi: 10.3816/CBC.2010.n.021.

14.

Protein modifications as potential biomarkers in breast cancer.

Jin H, Zangar RC.

Biomark Insights. 2009 Nov 30;4:191-200.

Supplemental Content

Support Center